Maelstrom Research Staging | TARGetKids!COVID19_Children_vaccination_study_group

TARGetKids!COVID19_Children_vaccination_study_group_Interview

Networks -

Variables -

Associated study TARGetKids!COVID19 Contingency Table

Population

TARGetKids!COVID19 - Children vaccination study group

The population is composed of children aged 0 to 16 years old attending scheduled health maintenance visit with their primary care physician.

Selection Criteria

Minimum age

Maximum age

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Exclusion: * Children with associated health conditions affecting growth (e.g., failure to thrive, cystic fibrosis). * Children with any acute or chronic conditions (other than asthma and high functioning autism). * Children with severe developmental delay.

Recruitment

Sources of recruitment

Participants from existing studies

Participants from Existing Studies

TARGetKids!

Number of Participants

Number of Participants: 1,123
Number of Participants with Biological Samples
Supplementary Information about selection criteria: 10 participants aged 10 years or older were selected for an interview.

More info

Data Collection Event

TARGetKids!COVID19 - Children vaccination study group - Interview

Information on participant's decisions regarding COVID-19 vaccinations (including views on evidence, trust, science, and the health care system.), and the context in which they make these decisions were assessed through an interview.

More info

Collected Dataset / TARGetKids!COVID19_Children_vaccination_study_group_Interview

TARGetKids!COVID19_Children_vaccination_study_group_Interview

Population

TARGetKids!COVID19 - Children vaccination study group

Data Collection Event

TARGetKids!COVID19 - Children vaccination study group - Interview

Files

Variables Classifications